Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Aarhus Tandcenter I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.1% 0.7% 0.9% 1.1% 1.4% 1.3% 4.4% 4.4%   Credit score (0-100)   85 95 90 83 78 79 47 47   Credit rating   A AA A A A A BBB BBB   Credit limit (kDKK)   463.5 1,345.2 1,435.6 617.8 112.9 258.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   29,237 26,338 33,277 0 0 0 0 0   Gross profit   8,728 18,719 22,633 25,004 26,688 28,886 0.0 0.0   EBITDA   7,176 5,223 8,085 4,474 3,950 5,588 0.0 0.0   EBIT   5,990 3,857 6,429 2,573 2,005 3,797 0.0 0.0   Pre-tax profit (PTP)   5,797.7 3,555.3 6,252.4 2,340.9 1,440.0 3,061.9 0.0 0.0   Net earnings   5,797.7 3,555.3 6,252.4 2,340.9 1,440.0 3,061.9 0.0 0.0   Pre-tax profit without non-rec. items   5,822 3,555 6,252 2,341 1,440 3,062 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   5,225 5,657 5,900 5,453 5,948 9,053 0.0 0.0   Shareholders equity total   9,917 9,177 11,262 9,828 7,780 10,445 0.0 0.0   Interest-bearing liabilities   3,796 3,752 2,219 5,670 5,922 6,644 7,135 7,135   Balance sheet total (assets)   16,472 17,713 17,288 18,337 17,053 19,787 7,135 7,135   Net Debt   3,743 3,656 2,218 5,626 5,867 6,496 7,135 7,135     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   29,237 26,338 33,277 0 0 0 0 0   Net sales growth   0.0% -9.9% 26.3% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   8,728 18,719 22,633 25,004 26,688 28,886 0.0 0.0   Gross profit growth   0.0% 114.5% 20.9% 10.5% 6.7% 8.2% -100.0% 0.0%   Employees   25 24 27 35 37 32 0 0   Employee growth %   0.0% -4.0% 12.5% 29.6% 5.7% -13.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   16,472 17,713 17,288 18,337 17,053 19,787 7,135 7,135   Balance sheet change%   0.0% 7.5% -2.4% 6.1% -7.0% 16.0% -63.9% 0.0%   Added value   7,176.5 5,222.7 8,085.2 4,473.7 3,905.5 5,588.0 0.0 0.0   Added value %   24.5% 19.8% 24.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   12,913 -724 -1,802 -2,867 -1,970 793 -9,053 0   Net sales trend   0.0 -1.0 1.0 -1.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   24.5% 19.8% 24.3% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   20.5% 14.6% 19.3% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   68.6% 20.6% 28.4% 10.3% 7.5% 13.1% 0.0% 0.0%   Net Earnings %   19.8% 13.5% 18.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   23.9% 18.7% 23.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   19.9% 13.5% 18.8% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   36.5% 22.6% 36.8% 14.5% 11.3% 20.7% 0.0% 0.0%   ROI %   43.9% 28.0% 47.1% 17.8% 13.8% 24.7% 0.0% 0.0%   ROE %   58.5% 37.2% 61.2% 22.2% 16.4% 33.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   60.2% 51.8% 65.1% 53.6% 45.6% 52.8% 0.0% 0.0%   Relative indebtedness %   22.4% 32.4% 18.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   22.2% 32.0% 18.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   52.2% 70.0% 27.4% 125.8% 148.6% 116.3% 0.0% 0.0%   Gearing %   38.3% 40.9% 19.7% 57.7% 76.1% 63.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.1% 8.3% 6.5% 6.1% 9.8% 11.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.2 0.2 0.3 0.4 0.2 0.2 0.0 0.0   Current Ratio   0.3 0.3 0.4 0.4 0.3 0.3 0.0 0.0   Cash and cash equivalent   52.8 95.5 0.6 44.0 54.9 147.4 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   5.3 8.3 9.8 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   29.5 24.6 33.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   6.4% 9.2% 6.4% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -4,675.5 -5,168.5 -3,884.6 -4,785.6 -6,951.0 -6,915.1 -3,567.6 -3,567.6   Net working capital %   -16.0% -19.6% -11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   1,169 1,097 1,232 0 0 0 0 0   Added value / employee   287 218 299 128 106 175 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   287 218 299 128 107 175 0 0   EBIT / employee   240 161 238 74 54 119 0 0   Net earnings / employee   232 148 232 67 39 96 0 0